We are live on ! Find out more
HDIM

Hanson & Doremus Investment Management Portfolio holdings

AUM $983M
1-Year Est. Return 34.23%
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
+34.23%
3 Year Est. Return
+80.83%
5 Year Est. Return
+81.33%
10 Year Est. Return
+253.13%
AUM
$234M
AUM Growth
-$2.47M
Cap. Flow
+$2.92M
Cap. Flow %
1.25%
Top 10 Hldgs %
25.36%
Holding
478
New
21
Increased
77
Reduced
122
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Financials 10.98%
3 Healthcare 10.41%
4 Industrials 8.86%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNP icon
401
Cohen & Steers REIT and Preferred and Income Fund
RNP
$971M
$5K ﹤0.01%
262
SBUX icon
402
Starbucks
SBUX
$122B
$5K ﹤0.01%
100
SCHE icon
403
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$5K ﹤0.01%
209
+113
+118% +$2.89K
AET
404
DELISTED
Aetna Inc
AET
$5K ﹤0.01%
38
BNS icon
405
Scotiabank
BNS
$108B
$4K ﹤0.01%
89
-1
-1% -$51
CVG
406
DELISTED
Convergys
CVG
$4K ﹤0.01%
150
KTEC
407
DELISTED
Key Technology Inc
KTEC
$4K ﹤0.01%
320
AEF
408
abrdn Emerging Markets Equity Income Fund
AEF
$371M
$3K ﹤0.01%
442
AMRN
409
Amarin Corp
AMRN
$296M
$3K ﹤0.01%
54
ARWR icon
410
Arrowhead Research
ARWR
$12.6B
$3K ﹤0.01%
470
FORM icon
411
FormFactor
FORM
$9.46B
$3K ﹤0.01%
350
RWO icon
412
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.27B
$3K ﹤0.01%
78
SBS icon
413
Sabesp
SBS
$17.7B
$3K ﹤0.01%
3,094
TM icon
414
Toyota
TM
$225B
$3K ﹤0.01%
23
VIRX
415
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3K ﹤0.01%
5
COHR
416
DELISTED
Coherent Inc
COHR
$3K ﹤0.01%
50
INVN
417
DELISTED
Invensense Inc
INVN
$3K ﹤0.01%
180
OII icon
418
Oceaneering
OII
$5.05B
$2K ﹤0.01%
50
WOR icon
419
Worthington Enterprises
WOR
$2.79B
$2K ﹤0.01%
130
SEEL
420
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
IRL
421
DELISTED
NEW IRELAND FUND INC
IRL
$2K ﹤0.01%
151
QGENF
422
DELISTED
QIAGEN NV
QGENF
$2K ﹤0.01%
100
FABC
423
Fabric.AI Inc
FABC
$18.4M
0
SCHZ icon
424
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$1K ﹤0.01%
20
APEN
425
DELISTED
Apollo Endosurgery, Inc.
APEN
$1K ﹤0.01%
51
+20
+65% +$1.98K

Similar funds

Hanson & Doremus Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Hanson & Doremus Investment Management held 478 positions worth $234M, down 1% from $237M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Hanson & Doremus Investment Management's Q2 2015 filing shows 21 new, 77 increased, 122 reduced and 28 closed positions. Its largest new stake was Monsanto Co: 4,661 shares worth $497K. The largest sale was Xerox, an estimated $354K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • Hanson & Doremus Investment Management's largest Q2 2015 buy was Monsanto Co: 4,661 shares worth $497K.
  • Hanson & Doremus Investment Management added most to Alphabet (Google) Class C in Q2 2015, an estimated $1.08M increase.
  • Hanson & Doremus Investment Management's biggest Q2 2015 reduction was Xerox, cutting an estimated $354K.
  • Hanson & Doremus Investment Management fully exited iShares MSCI KLD 400 Social ETF in Q2 2015, selling an estimated $66K.
  • Hanson & Doremus Investment Management's ten largest holdings make up 25% of its $234M portfolio in Q2 2015.
  • Hanson & Doremus Investment Management opened 21 new positions and closed 28 in Q2 2015.
  • Hanson & Doremus Investment Management's portfolio value fell 1% quarter-over-quarter to $234M.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2015, filed 31 Jul 2015.